ALPI and colitis: Significantly lower serum IAP levels in the groups treated with MSB, MM, or both compared to those in the AA group may be caused by the prophylactic administration of these substances prior to the induction of colitis, which may preserve and even improve intestinal and systemic health, thus contributing to a reduction in the effect of AA in the colon.